61 results
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Polyangiitis (MPA) - ANCA ... Vasculitis Management ... Algorithm - ACR ... Polyangiitis #MPA #ANCA ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Polyangiitis (EGPA) - ANCA ... Vasculitis Management ... Algorithm - ACR ... #Polyangiitis #ANCA ... #rheumatology
Rapidly Progressive Glomerulonephritis (RPGN)
RPGN has three primary pathophysiologic causes differentiated by immunofluorescence

Immune Complex Mediated (granular staining):
(C-ANCA): GPA > ... > eGPA • MPO-ANCA ... (P-ANCA): eGPA, ... differential #diagnosis #algorithm ... #rheumatology
Gout Management Algorithm

DOI: 10.1016/j.semarthrit.2020.04.010

#Gout #Management #Algorithm #rheumatology #uricacid
Gout Management ... Algorithm DOI: ... .2020.04.010 #Gout #Management ... #Algorithm #rheumatology
ANCA-Associated Vasculitis
There are many definitions, but most come down to the presence of granulomas (pathologically or
ANCA-Associated ... StanfordChiefs #ANCA ... differential #diagnosis #algorithm ... #rheumatology
Diagnosis and management of Polyarteritis Nodosa (PAN)

Chapel Hill 2012 definition: 
Necrotizing vasculitis ofmedium or small arteries
Diagnosis and management ... associated with ANCA ... PolyarteritisNodosa #Rheumatology ... #Diagnosis #Management
Thrombotic Microangiopathy (TMA) - Diagnosis and Management Algorithm

#Thrombotic #Microangiopathy #TMA #Diagnosis #Management #Algorithm #hematology
Diagnosis and Management ... Algorithm #Thrombotic ... TMA #Diagnosis #Management ... #Algorithm #hematology
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
Guidelines for Management ... #GCA #ACR2021 #Management ... #rheumatology # ... algorithm #vasculitis
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... Workup: - ANA ... 50-60% - pANCA ... Usual therapeutic management ... #Summary #rheumatology
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Algorithm for the ... Evaluation and Management ... #Diagnosis #Management ... #Hematology #SickleCell ... Manifestations #Workup #Algorithm